If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntegraFin Holdings Regulatory News (IHP)

Share Price Information for IntegraFin Holdings (IHP)

Share Price is delayed by 15 minutes
Get Live Data
372.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (0.134%)
Market Cap: £1.23b
IHP Live PriceLast checked at - London Stock Exchange

Intraday IntegraFin Holdings Share Chart

2nd Quarter Results

16 Apr 2024 07:15

RNS Number : 7020K
IntegraFin Holdings plc
16 April 2024
Β 

LEI Number: 213800CYIZKXK9PQYE87

Β 

Β 

16 April 2024

Β 

Β 

IntegraFin Holdings plc

Q2 Trading Update

Β 

IntegraFin Holdings plc ("IHP" or "the Group"), operator of Transact, the UK's premium investment platform for clients and UK financial advisers, is pleased to update on performance for the three months ended 31 March 2024.

Β 

The Group has continued to demonstrate strong momentum with continued growth of the Transact platform.

Β 

Group highlights

Β 

Β· Record quarter end funds under direction (FUD) on the Transact platform of Β£61.0bn, up 13% over the past year.

Β 

Β· Record average daily FUD for the quarter of Β£58.6bn in Q2 FY24 (Q2 FY23: Β£53.8bn).

Β 

Β· Total Group revenue is expected to be c.Β£70m for H1 FY24 (H1 FY23: Β£66.5m).

Β 

Β· Guidance issued at year end FY23 remains unchanged for FY24 (ending 30 September 2024).

Β 

Β 

Transact Platform

Β· Total net inflows to the Transact platform for H1 FY24 of Β£1.1bn.

Β 

Β· Resilient Q2 FY24 flows to the Transact platform, with net inflows of Β£0.8bn, and gross inflows of Β£2.3bn.

Β 

Β· Ongoing growth of the Transact platform's client base with 5.4k gross new clients registered in Q2, in addition to continued growth of the adviser base on the platform with 255 gross new advisers registered.

Β 

Β· During Q2, our recurring account closure exercise for clients who have only small residual balances resulted in a reduction in client numbers of c.2.5k and registered advisers of c.150. This helps improve operational efficiency and has no material effect on our revenues or FUD levels on the platform.

Β 

Time4Advice

Β 

Β· Time4Advice demonstrated continuing progress, with total chargeable users of CURO software now at over 3.0k, up 21% over the past year.

Β 

Β 

Transact platform reporting for Q2 FY24:

Β 

Β 

Β 

Β 

Β£m

Β Quarter ended

31 March 2024

Quarter ended

31 March 2023

H1 ended

31 March 2024

H1 ended

31 March 2023

Opening FUD

58,010

52,063

54,959

50,070

Inflows

2,268

1,825

3,925

3,294

Outflows

-1,478

-900

-2,867

-1,669

Net flows

790

925

1,058

1,625

Market movements

2,196

994

4,982

2,313

Other movements(1)

24

-9

21

-35

Closing FUD

61,020

53,973

61,020

53,973

Average daily FUD for the period (Β£m)

58,567

53,842

57,012

52,643

Number of registered advisers

7,849

7,563

7,849

7,563

Number of platform clients

231,581

228,232

231,581

228,232

Notes:(1)Includes fees, taxes and investment income.

Β 

Β 

Β 

Alex Scott, IHP Group Chief Executive Officer, commented:

Β 

"I am pleased to see the Transact platform continue to prove its resilience within the current market environment with another quarter of solid net inflows. The platform delivered net inflows of Β£0.8bn for the quarter and Β£1.1bn in H1 FY24.

Β 

I'm further pleased to see Transact platform FUD reach a record high of Β£61.0bn, alongside continued additions to the number of advisers and clients on the platform.

Β 

Our continued focus on delivering good client outcomes and market leading customer service will ensure that the Transact platform continues to appeal to clients and advisers, thereby supporting the Group's long-term growth."

Β 

Β 

Β 

Β 

Β 

Β 

Notice of interim results

Β 

The Group will announce its results for the six months ended 31 March 2024 on 22 May 2024.

Β 

Β 

Β 

Β 

Β 

Transact platform historical information:

Β 

Β£m

Q3

FY22

Q4

FY22

Q1 FY23

Q2 FY23

Q3

FY23

Q4 FY23

Q1 FY24

Q2 FY24

Opening FUD

53,500

50,300

50,070

52,063

53,973

54,606

54,959

58,010

Inflows

1,703

1,505

1,469

1,825

1,517

1,595

1,657

2,268

Outflows

-703

-785

-769

-900

-900

-1,184

-1,389

-1,478

Net flows

1,000

720

700

925

617

411

268

790

Market movements

-4,152

-927

1,319

994

21

-62

2,786

2,196

Other movements(1)

-48

-23

-26

-9

-5

4

-3

24

Closing FUD

50,300

50,070

52,063

53,973

54,606

54,959

58,010

61,020

Average daily FUD for the period (Β£m)

51,889

52,217

51,470

53,842

54,288

54,964

55,474

58,567

Number of registered advisers

7,469

7,537

7,632

7,563

7,606

7,683

7,820

7,849

Number of platform clients

221,992

224,705

226,996

228,232

229,659

230,294

231,413

231,581

Notes:(1)Includes fees, taxes and investment income.

Β 

Β 

Β 

Enquiries

Β 

Investors

Β 

Luke Carrivick, IHP Head of Investor Relations

+44 020 7608 5463

Media

Β 

IHP@fgsglobal.com

FGS Global: Mike Turner

FGS Global: Chris Sibbald

+44 7775992415

+44 7855955531

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTGPUBGCUPCGMA
Date   Source Headline
29th Jun 202612:06 pmRNSDirector/PDMR Shareholding
29th Jun 20269:52 amRNSHolding(s) in Company
23rd Jun 20265:14 pmRNSDirector/PDMR Shareholding
17th Jun 20264:38 pmRNSHolding(s) in Company
22nd May 202610:49 amRNSDirector/PDMR Shareholding
21st May 20269:55 amRNSDirector/PDMR Shareholding
20th May 20267:00 amRNSHalf-year Financial Report
7th May 20263:35 pmRNSHolding(s) in Company
22nd Apr 20263:35 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNSQ2 Trading Update
10th Apr 202610:24 amRNSHolding(s) in Company
30th Mar 202611:39 amRNSHolding(s) in Company
24th Mar 202610:49 amRNSDirector/PDMR Shareholding
16th Mar 20263:39 pmRNSHolding(s) in Company
16th Mar 20263:39 pmRNSHolding(s) in Company
27th Feb 20267:00 amRNSResult of AGM
24th Feb 20264:13 pmRNSDirector/PDMR Shareholding
23rd Feb 20269:45 amRNSHolding(s) in Company
19th Feb 202612:06 pmRNSHolding(s) in Company
12th Feb 202612:14 pmRNSDirector/PDMR Shareholding
2nd Feb 202612:39 pmRNSDirector/PDMR Shareholding
22nd Jan 20262:14 pmRNSDirector/PDMR Shareholding
13th Jan 20265:09 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNS1st Quarter Results
9th Jan 202611:49 amRNSAnnual Financial Report
30th Dec 202512:49 pmRNSHolding(s) in Company
30th Dec 202512:49 pmRNSHolding(s) in Company
24th Dec 202511:14 amRNSDirector/PDMR Shareholding
24th Dec 202511:14 amRNSDirector/PDMR Shareholding
19th Dec 202512:30 pmRNSDirector/PDMR Shareholding
19th Dec 202512:30 pmRNSDirector/PDMR Shareholding
18th Dec 202512:59 pmRNSDirector/PDMR Shareholding
18th Dec 202512:59 pmRNSDirector/PDMR Shareholding
17th Dec 20257:00 amRNSFinal Results
25th Nov 20259:45 amRNSDirector/PDMR Shareholding
7th Nov 20257:00 amRNSReplacement: Holding(s) in Company
6th Nov 20254:03 pmRNSHolding(s) in Company
3rd Nov 20253:03 pmRNSHolding(s) in Company
28th Oct 20255:17 pmRNSHolding(s) in Company
22nd Oct 20255:02 pmRNSDirector/PDMR Shareholding
14th Oct 20257:00 amRNSQ4 Trading Update
10th Oct 20251:46 pmRNSHolding(s) in Company
29th Sep 20254:40 pmRNSDirector/PDMR Shareholding
23rd Sep 202511:26 amRNSDirector/PDMR Shareholding
22nd Sep 202511:15 amRNSHolding(s) in Company
19th Sep 202512:46 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
5th Sep 202512:00 pmRNSChange of Registered Office
1st Sep 202512:00 pmRNSHolding(s) in Company
26th Aug 202510:35 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.